门冬胰岛素30与盐酸吡格列酮联合治疗对2型糖尿病患者血糖的影响被引量：1

Effects of combination of insulin Aspart 30 and pioglitazone hydrochloride on blood glucose in type 2 diabetes mellitus patients

下载PDF

导出

摘要目的:观察门冬胰岛素30(诺和锐30)和盐酸吡格列酮(瑞彤)联合治疗对2型糖尿病(T2DM)患者血糖的影响。方法:选择60例经诺和锐30强化血糖控制达标2周后患者,随机分为诺和锐30联合瑞彤观察组29例和诺和锐30单用对照组31例,比较2组各时段血糖水平、糖化血红蛋白(HbA1C)含量和24h胰岛素用量。结果:与对照组比较,观察组在早餐前和三餐后30min、60min、120min血糖下降(P<0.05或0.01),HbA1C下降(P=0.042);且24h胰岛素用量减少(P<0.0001)。结论:T2DM患者早期联合噻唑烷二酮类胰岛素增敏剂治疗,可降低胰岛素抵抗,改善血糖控制。 Aim： To investigate the blood glucose changes in patients with type 2 diabetes mellitus （T2DM） after the treatment with Insulin Aspart 30（NovoRapid30） and pioglitazone.hydrochloride. Methods： A total of 60 cases of T2DM, whose blood glucose reached the control standard after two weeks＇NovoRapid30 intensive treatment, were allocated into the treatment group（29 cases） treated with NovoRapid30 and pioglitazone hydrochloride, and the control group （31 cases） treated with NovoRapid30 ; The blood glucose changes, HbAI C content, and insulin dose during different periods of the two groups were detected. Results： Compared with the control group, the blood glucose in the treatment group decreased significantly before breakfast and at 30 min, 60 min, and 120 min after 3 meals （P 〈 0.05 or 0.01 ）. The decrease of HbA1c was also obvious （P = 0. 042）. And the 24 h insulin consumption decreased （P 〈 0. 000 1 ）. Conclusion： The early combination of thiazolidinedione in the treatment of T2DM could decrease the insulin resistance and improve the blood glucose level.

作者董健代芳王亚林于瑞萍刘波

机构地区贵州省人民医院内分泌科贵阳中医学院附一院内分泌科

出处《郑州大学学报（医学版）》 CAS 北大核心 2006年第5期936-938,共3页 Journal of Zhengzhou University(Medical Sciences)

关键词 2型糖尿病胰岛素盐酸吡格列酮血糖 type 2 diabetes mellitus pancreatic beta-cell insulin PPARγ

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献5

1Walter H,Lubben G.Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.Drugs,2005,65 (1):1
2Bautista JL,Bugos C,Dirnberger G,et al.The efficacy and safety of Amaryl as compared to Placebo in Mexicam-Amenicans with type 2 diabetes inadequately controlled by exercise and diet alone (abstract).Diabetes Res Clin Pract,2000,50 (Suppl 1):S46
3UK Prospective Diabetes Study Group.UK Prospective Diabetes Study 16:overview of 6 year's therapy of type Ⅱ diabetes a progressive disease.Diabetes,1995,44(11):1 249
4Tian YM,Johnson G,Ashcroft SJH.Sulfonycureas enhance exocylosis from pancreatic β-cells by a mechanism that does not involve direct activation of protein Kinase C.Diabetes,1998,47(11):1 722
5邹大进,张丽娟.吡格列酮在不同阶段糖尿病治疗中的合理使用[J].实用糖尿病杂志,2005,1(6):56-57. 被引量：3

二级参考文献12

1Walter H,Lubben G.Potential role of oral thiazolidinedione therapy in preserving beta - cell function in type 2 diabetes mellitus.Drugs 2005;65(1):1-13.
2Kipnes MS,Krosnick A,Rendell MS,et al.Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus:a randomized,placebo - controlled study.Am J Med 2001 Jul; 111 (1):10 -17.
3Miyazaki Y,Mahankali A,Matsuda M,et al,Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.Diabetes Care 2001 Apr; 24 (4):710-719.
4Kawamori R,Matsuhisa M,Kinoshita J,et al.Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in non - insulin - dependent diabetes mellitus.AD - 4833 Clamp - OGL Study Group.Diabetes Res Clin Pract 1998 Jul;41(1) :35 -43.
5Kemnitz JW,Elson DF,Roecker EB,et al.Pioglitazone increases insulin sensitivity,reduces blood glucose,insulin,and lipid levels,and lowers blood pressure,in boese,insulin - resistant rhesus monkeys.Diabetes 1994 Feb;43(2) :204- 211.
6Yamaguchi M,Nishimura F,Naruishi H,et al.Thiazolidinedione(pioglitazone)blocks P.gingivalis - and F.nucleatum,but not E.coli,lipopolysaccharide(LPS) - induced interleukin - 6 (IL - 6) production in adipocytes.J Dent Res 2005 Mar; 84 (3):240 - 244.
7Yang WS,Jeng CY,Wu TJ,et al.Synthetic peroxisome proliferator- activated receptor - gamma agonist,rosiglitazone,increases plasma levels of adiponectin in type 2 diabetic patients.Diabetes Care 2002 Feb;25(2) :376 - 380.
8Durbin RJ.Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance.Diabetes Obes Metab 2004 Jul;6(4):280- 285.
9Charbonnel BH,Matthews DR,Schemthaner G,et al.A long - term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus:a randomized,double - blind,parallel - group comparison trial.Diabet Med 2005 Apr;22(4) :399 - 405.
10Ceriello A,Johns D,Widel M,et al.Comparison of effect of piolitazone with metformin or sulfonylurea(monotherapy and combination therapy)on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes.Diabetes Care 2005 Feb;28(2) :266 - 272.